Dozee's AI Predicts Health Deterioration 16 Hours Early in Advance

Dozee, India’s Health AI leader, has unveiled the findings of a landmark study published in the internationally renowned journal Frontiers in Medical Technology. This journal is part of the prestigious Frontiers group. The study was conducted at...

Medtronic Gains US FDA Nod for AFib Mapping and Ablation System

Medtronic plc, a prominent player in healthcare technology worldwide, revealed that the FDA has given the green light for the Affera Mapping and Ablation System with Sphere-9 catheter, a comprehensive HD mapping and PF/RF ablation catheter for...

MHRA Speeds Up Global Polio Eradication with Advanced Detection Method

MHRA is showcasing efforts to train various WHO polio labs worldwide with an advanced molecular direct detection technique that can reduce detection times by 50%, aiding in the global push to eliminate polio and save lives...

Abbott's TEAM-HF Trial Aims Early Intervention in High-Risk Heart Failure

Abbott introduced a unique clinical trial aimed at enhancing results in patients with worsening heart failure who may benefit from advanced treatment choices. The TEAM-HF study aims to include a maximum of 850 participants from 75 locations...

Bayer and Dewpoint Therapeutics Ink Pact for Heart Disease Program

Bayer has made an exclusive deal with Dewpoint Therapeutics, Inc. for a heart disease program targeting dilated cardiomyopathy (DCM) patients with specific mutations. This marks the initial opportunity for collaboration between Bayer and Dewpoint...

Matica Biotech and KaliVir Ink LOI for Oncolytic Viral Immunotherapy Ties

Matica Biotechnology Inc. (Matica Bio), a company specializing in viral vector development and manufacturing, has revealed the signing of a Letter of Intent (LOI) with KaliVir Immunotherapeutics, a clinical-stage biotechnology company from the U.S...

Merck's Keytruda Bags European Nod for indications in Gynaecologic Cancers

Merck, a leading pharmaceutical firm, stated that Keytruda (pembrolizumab), their anti-PD-1 therapy, has received approval from the European Commission (EC) for two additional uses in gynaecologic cancers. Keytruda has received initial approval...

Thermo Fisher and Telangana Govt to Set Up Bioprocess Design Centre

Thermo Fisher Scientific signed a Memorandum of Understanding (MoU) with the Telangana Government to set up a bioprocess design centre (BDC) in Genome Valley, Hyderabad. With a total area of 10,000 sq. ft., the bioprocess design center is...

The Pharma Manufacturing & Automation Excellence Awards 2024 - A Celebration of Innovation, Excellence, and Leadership

The Pharma Manufacturing & Automation Excellence Awards 2024, hosted by Eminence Business Media, witnessed an incredible night of celebration, innovation, and recognition, marking the maiden edition of what promises to become a hallmark event.

The 6th Annual Pharma Manufacturing and Automation Convention 2024 took place in Hyderabad

The 6th Annual Pharma Manufacturing and Automation Convention 2024 took place on October 17th and 18th at the Hotel Westin Mindspace in Hyderabad. The event brought together industry leaders to discuss the future of intelligent manufacturing.

© 2024 India Pharma Outlook. All Rights Reserved.